Literature DB >> 29985540

Drug-induced thrombotic microangiopathy: An updated systematic review, 2014-2018.

Rabia Saleem1, Jessica A Reese2, James N George1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29985540     DOI: 10.1002/ajh.25208

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

Review 1.  Thrombotic microangiopathies: An illustrated review.

Authors:  Mouhamed Yazan Abou-Ismail; Sargam Kapoor; Divyaswathi Citla Sridhar; Lalitha Nayak; Sanjay Ahuja
Journal:  Res Pract Thromb Haemost       Date:  2022-04-22

Review 2.  Kidney injury and disease in patients with haematological malignancies.

Authors:  Frank Bridoux; Paul Cockwell; Ilya Glezerman; Victoria Gutgarts; Jonathan J Hogan; Kenar D Jhaveri; Florent Joly; Samih H Nasr; Deirdre Sawinski; Nelson Leung
Journal:  Nat Rev Nephrol       Date:  2021-03-30       Impact factor: 28.314

Review 3.  Severe thrombocytopenia and microangiopathic hemolytic anemia in pregnancy: A guide for the consulting hematologist.

Authors:  Juliana Perez Botero; Jessica A Reese; James N George; Jennifer J McIntosh
Journal:  Am J Hematol       Date:  2021-09-04       Impact factor: 10.047

4.  An Update in Drug-Induced Thrombotic Microangiopathy.

Authors:  Thomas Chatzikonstantinou; Maria Gavriilaki; Achilles Anagnostopoulos; Eleni Gavriilaki
Journal:  Front Med (Lausanne)       Date:  2020-05-22

Review 5.  Thrombotic Microangiopathy, an Unusual Form of Monoclonal Gammopathy of Renal Significance: Report of 3 Cases and Literature Review.

Authors:  Edward J Filippone; Eric D Newman; Li Li; Rakesh Gulati; John L Farber
Journal:  Front Immunol       Date:  2021-11-10       Impact factor: 7.561

6.  Thrombotic microangiopathy (TMA) in adult patients with solid tumors: a challenging complication in the era of emerging anticancer therapies.

Authors:  Carme Font; Marta García de Herreros; Nikolaos Tsoukalas; Norman Brito-Dellan; Francis Espósito; Carmen Escalante; Thein Hlaing Oo
Journal:  Support Care Cancer       Date:  2022-05-12       Impact factor: 3.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.